Literature DB >> 11687626

The infiltration kinetics of simian immunodeficiency virus-specific T cells drawn to sites of high antigenic stimulation determines local in vivo viral escape.

P Blancou1, N Chenciner, M C Cumont, S Wain-Hobson, B Hurtrel, R Cheynier.   

Abstract

Despite vigorous cell-mediated immune responses to human and simian immunodeficiency viruses (HIV/SIV) the immune system is unable to clear latently infected resting T cells. These infected cells are reactivated by antigenic stimulation, leading to viral replication. By using the SIV/macaque model of HIV pathogenesis, the dynamics of T cell infiltration into delayed type hypersensitivity sites specific for the purified protein derivative of bacillus Calmette-Guérin have been studied. Early viral mRNA synthesis coincided with the infiltration of antigen-specific T cells. When the infiltration of anti-SIV-specific T cells was rapid compared with the kinetics of viral assembly, the sites were sterilized before the transition to late viral mRNA synthesis occurred. When their infiltration was slow, ephemeral foci of replication were identified. These findings were paralleled by plasma viremia; low viremia coincided with rapid sterilization of the delayed type hypersensitivity sites, whereas high load was found in association with local replication and delayed sterilization. These data suggest that although effective local control of SIV is possible once antiviral T lymphocytes have arrived on site, the slower deployment of these T cells may allow the virus to escape and thus to reseed the pool of memory T cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11687626      PMCID: PMC60854          DOI: 10.1073/pnas.231348598

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  Nucleotide sequence of the visna lentivirus: relationship to the AIDS virus.

Authors:  P Sonigo; M Alizon; K Staskus; D Klatzmann; S Cole; O Danos; E Retzel; P Tiollais; A Haase; S Wain-Hobson
Journal:  Cell       Date:  1985-08       Impact factor: 41.582

2.  Latent reservoirs of HIV: obstacles to the eradication of virus.

Authors:  T W Chun; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

3.  HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides.

Authors:  D F Nixon; A R Townsend; J G Elvin; C R Rizza; J Gallwey; A J McMichael
Journal:  Nature       Date:  1988-12-01       Impact factor: 49.962

4.  HIV-specific effector cytotoxic T lymphocytes and HIV-producing cells colocalize in white pulps and germinal centers from infected patients.

Authors:  A Hosmalin; A Samri; M J Dumaurier; Y Dudoit; E Oksenhendler; M Karmochkine; B Autran; S Wain-Hobson; R Cheynier
Journal:  Blood       Date:  2001-05-01       Impact factor: 22.113

5.  Temporal loss of Nef-epitope CTL recognition following macaque lipopeptide immunization and SIV challenge.

Authors:  L Mortara; F Letourneur; P Villefroy; C Beyer; H Gras-Masse; J G Guillet; I Bourgault-Villada
Journal:  Virology       Date:  2000-12-20       Impact factor: 3.616

6.  Highly restricted spread of HIV-1 and multiply infected cells within splenic germinal centers.

Authors:  S Gratton; R Cheynier; M J Dumaurier; E Oksenhendler; S Wain-Hobson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

7.  The HIV-1 regulatory proteins Tat and Rev are frequently targeted by cytotoxic T lymphocytes derived from HIV-1-infected individuals.

Authors:  M M Addo; M Altfeld; E S Rosenberg; R L Eldridge; M N Philips; K Habeeb; A Khatri; C Brander; G K Robbins; G P Mazzara; P J Goulder; B D Walker
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

8.  Temporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection: evidence for differential gene expression.

Authors:  S Y Kim; R Byrn; J Groopman; D Baltimore
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

9.  A Trojan Horse mechanism for the spread of visna virus in monocytes.

Authors:  R Peluso; A Haase; L Stowring; M Edwards; P Ventura
Journal:  Virology       Date:  1985-11       Impact factor: 3.616

10.  Vaccination with tat toxoid attenuates disease in simian/HIV-challenged macaques.

Authors:  C D Pauza; P Trivedi; M Wallace; T J Ruckwardt; H Le Buanec; W Lu; B Bizzini; A Burny; D Zagury; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

View more
  6 in total

1.  Macaque studies of vaccine and microbicide combinations for preventing HIV-1 sexual transmission.

Authors:  Dan H Barouch; Per Johan Klasse; Jason Dufour; Ronald S Veazey; John P Moore
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-14       Impact factor: 11.205

2.  Antigenic stimulation specifically reactivates the replication of archived simian immunodeficiency virus genomes in chronically infected macaques.

Authors:  Céline Renoux; Simon Wain-Hobson; Bruno Hurtrel; Rémi Cheynier
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

3.  Simian immunodeficiency virus promoter exchange results in a highly attenuated strain that protects against uncloned challenge virus.

Authors:  Philippe Blancou; Nicole Chenciner; Raphaël Ho Tsong Fang; Valérie Monceaux; Marie-Christine Cumont; Denise Guétard; Bruno Hurtrel; Simon Wain-Hobson
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

4.  Killing of targets by CD8 T cells in the mouse spleen follows the law of mass action.

Authors:  Vitaly V Ganusov; Daniel L Barber; Rob J De Boer
Journal:  PLoS One       Date:  2011-01-24       Impact factor: 3.240

5.  Spatiotemporal Dynamics of Virus Infection Spreading in Tissues.

Authors:  Gennady Bocharov; Andreas Meyerhans; Nickolai Bessonov; Sergei Trofimchuk; Vitaly Volpert
Journal:  PLoS One       Date:  2016-12-20       Impact factor: 3.240

Review 6.  Cat and Mouse: HIV Transcription in Latency, Immune Evasion and Cure/Remission Strategies.

Authors:  Aurélie Delannoy; Mikaël Poirier; Brendan Bell
Journal:  Viruses       Date:  2019-03-18       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.